• Info
  • Insider Ownership

Insider Trading & Ownership of Charles W. Newton

Location
Atherton, CA
Summary
The estimated net worth of Charles W. Newton is at least $565,269 dollars as of 11 Mar 2026. Charles W. Newton is the Chief Financial Officer of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $290.1K. Charles W. Newton is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $227.8K. Charles W. Newton is the Director of 2seventy bio, Inc. and owns shares of 2seventy bio, Inc. stock worth about $47.4K.
Signature
/s/ Esther Cho, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Charles W. Newton files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Charles W. Newton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LYEL Lyell Immunopharma, Inc. Chief Financial Officer $290,086 +$93,515 +48% 20 Aug 2025
KROS Keros Therapeutics, Inc. Director $227,826 09 Mar 2026
TSVT 2seventy bio, Inc. Director $47,357 13 May 2025
CHRS Coherus Oncology, Inc. Director 12 Jun 2025
NVAX NOVAVAX INC Director 25 Apr 2025

Insider Transactions Reported by Charles W. Newton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.